Download 13_ID

ID Proposals_Final
Name: Stephanie Pouch
Institution: The Ohio State University College of Medicine
Email: [email protected]
Did you submit this proposal on behalf of an ASTS or AST committee?: No
If yes, please indicate which committee:
Specialty: Heart
Infectious Disease
Kidney
Liver
Lung
Pancreas
Presentation Type: Interactive (Smaller group or round table) Symposium
Proposed Session Title: The MDRO-Colonized Recipient: Challenges and Strategies for Optimizing
Outcomes
Proposed Moderators: Stephanie Pouch, MD, MS, The Ohio State University College of Medicine and
Shirish Huprikar*, MD, Icahn School of Medicine at Mount Sinai
*Camille Kotton – might replace SH here as he’s speaking elsehwere. Other potential speakers (from
other program submissions):
Dong Heun Lee, Drexel (has data on MDR swabs and SOT)
David van Duin, UNC
Dan Kaul, Michigan
Ann Misch UWisc
Goals and Objectives: Multidrug-resistant organisms (MDROs), including methicillin-resistant
Staphylococcus aureus, vancomycin- and daptomycin-resistant enterococci, carbapenem-resistant
Enterobacteriaceae, and multidrug-resistant Pseudomonas aeruginosa, and Burkholderia spp., pose a
serious threat to patient and graft survival, and limited therapeutic options often necessitate the use of
older, toxic antimicrobials. Furthermore, the optimal management of transplant recipients with a
history of pre-transplant colonization or infection due to MDROs remains unclear.
The goals and objectives of this IDCOP-sponsored, interactive, case-based symposium are for the
participant to understand:
1.The impact of recipient pre-transplant MDRO colonization/infection on post-transplant outcomes.
2.Waitlist management strategies (e.g., decolonization) for patients listed for transplantation who have
a history of MDRO colonization/infection.
3.Peri- and post-operative management of organ transplant recipients colonized with MDROs (e.g.,
alteration of perioperative prophylaxis, duration of therapy).
ID Proposals_Final
Name: Shirish Huprikar
Institution: Mount Sinai
Email: [email protected]
Camille Kotton – outstanding speakers, cutting edge information, top tier priority for ID and transplant
community at large
Did you submit this proposal on behalf of an ASTS or AST committee?: Yes
If yes, please indicate which committee: ID COP
Specialty: Administrative
Heart
Infectious Disease
Kidney
Liver
Pancreas
Pediatric
Pharmacy
Small Bowel
Presentation Type: Lecture/Didactic Symposium
Proposed Session Title: Infected Donors: Expanding the Donor Pool & The Risk of Avoiding All Risk
Proposed Moderators: Mike Ison, Northwestern and Cameron Wolfe, Duke
Presentation #1: PHS Increased Donors: Can We Do More?
Proposed Speaker: Nicole Theodoropolous, University of Massachusetts
Presentation #2: DTAC Perspectives on Expanding the Donor Pool
Proposed Speaker: Cameron Wolfe, Duke
Presentation #3: Hepatitis C D+R-: The New Frontier?
Proposed Speaker: Peter Reese, University of Pennsylvania
Goals and Objectives: Highlight the infected donor as an opportunity to safely expand the donor pool
ID Proposals_Final
Name: Joanna Schaenman
Institution: David Geffen School of Medicine at UCLA
Email: [email protected]
Camille Kotton – outstanding speakers, cutting edge information, top tier priority for ID and transplant
community at large, one of our most well attended sessions every year, and this one covers both the
basics and cutting edge information.
Did you submit this proposal on behalf of an ASTS or AST committee?: No
If yes, please indicate which committee:
Specialty: Basic Science/Immunology
Heart
Infectious Disease
Kidney
Liver
Lung
Pancreas
Pediatric
Pharmacy
Small Bowel
Translational
Vascularized Composite Allograft
Presentation Type: Lecture/Didactic Symposium
Proposed Session Title: CMV in 2017: What’s Hot, What’s New?
Proposed Moderators: Deepali Kumar, University of Toronto and Raymund Razonable, Mayo Clinic
Presentation #1: Negative Impacts of CMV on the Transplant Allograft & Optimal Prevention
Proposed Speaker: Raymund Razonable, Mayo Clinic
Presentation #2: The T Cell Response to CMV Infection: Bench to Bedside
Proposed Speaker: Laurie Snyder, Duke University
Presentation #3: Anti-CMV Armamentarium of the Future
Proposed Speaker: Camille Kotton, Massachusetts General
Goals and Objectives: This session has been endorsed by the Infectious Diseases, Basic Science, and
Kidney/Pancreas COPs.
Objectives:
CMV infection continues to cause significant morbidity and mortality after solid organ transplant, and
has also been implicated in causing negative impact on the transplant allograft. This symposium will
review the latest discoveries in the field as they apply to the clinical care of transplant patients at risk for
CMV infection and disease. This will include insights into CMV immunology and new potential bench-tobedside applications for monitoring; new approaches to treatment including updates on new antiviral
therapies, vaccines, and other avenues for treatment; and the latest data on the deleterious effects of
ID Proposals_Final
CMV replication on the allograft. In addition to filling a gap in knowledge of CMV disease, this session
will provide an opportunity for interaction between basic scientists and clinicians.
Goals:
1.
Describe the new antiviral medications in development for treatment of CMV as well as current
vaccine trials, and the promise of adaptive cell transfer for treatment of CMV.
2.
Understand the CMV virus-specific immune response as measured both in the basic science
laboratory as well as the potential for new clinically useful testing modalities for measurement of an
effective anti-CMV response in patients.
3.
Understand the data linking CMV infection and negative allograft outcomes and the potential
mechanism of this effect, including promotion of antibody production, stimulation of inflammation, and
upregulation of fibrosis.
ID Proposals_Final
Name: Christie Thomas
Institution: University of Iowa
Email: [email protected]
Camille Kotton – are there other BK symposia? I don’t see any. (If so, might pick those.) This is a bit
obscure. I think many people want bread and butter info on BK. Perhaps we can discuss as a larger
group? Based on unusual content, I would say this is lower tier priority for ID.
Did you submit this proposal on behalf of an ASTS or AST committee?: No
If yes, please indicate which committee:
Specialty: Heart
Infectious Disease
Kidney
Liver
Lung
Pancreas
Presentation Type: Lecture/Didactic Symposium
Proposed Session Title: Kidney disease and more in BKPyV infection: nephropathy in non-renal organ
recipients; urinary tumorigenesis and therapeutic approaches
Proposed Moderators: Volker Nickeleit MD, University of North Carolina and Christie P Thomas MD,
University of Iowa
Presentation #1: BKPyV and Urinary tumors
Proposed Speaker: John C. Papadimitrou MD, PhD, University of Maryland
Presentation #2: BKPyV nephropathy in non renal solid organ transplant recipients
Proposed Speaker: Sarat Kuppachi MD, University of Iowa
Presentation #3: Prevention and treatment of BKPyV infection and nephropathy: current solutions and
future promises
Proposed Speaker: John S Gill MD, University of British Columbia
Goals and Objectives: BK polyoma virus (BKPyV)is a well-recognized cause of tubulointerstitial nephritis
and progressive chronic kidney disease in kidney transplant recipients. Despite advances in screening
and detection of BKPyV infection in this immunocompromised population, there are limited therapeutic
options that have been shown to be of benefit. It has recently become clear that BKPyV like other
polyoma viruses may be an oncovirus leading to urinary tumors. BKPyV induced nephropathy is also
beginning to be recognized as a cause of CKD in non-renal solid organ transplant (NRSOT) recipients.
The purpose of this symposium is to discuss emerging information about BKPyV and urothelial
malignancies and to inform the attendees about the problem of BKPyV nephropathy following NRSOT
and to provide an uptodate discussion of current therapies and new treatments that may be on the
horizon. The symposium will be led by 3 leaders in their field.
Relevant speaker publication:
ID Proposals_Final
JC Papadimitrou: http://www.ncbi.nlm.nih.gov/pubmed/26731714
Sarat Kuppachi: http://www.ncbi.nlm.nih.gov/pubmed/26985385
JS Gill: http://www.ncbi.nlm.nih.gov/pubmed/27257795
ID Proposals_Final
Name: Shirish Huprikar
Institution: Mount Sinai
Email: [email protected]
Camille Kotton – outstanding speakers, cutting edge information, top tier priority for ID and transplant
community at large. This was hugely successful last year, hundreds of people at 7am on a Sunday.
Did you submit this proposal on behalf of an ASTS or AST committee?: Yes
If yes, please indicate which committee: ID COP
Specialty: Heart
Infectious Disease
Kidney
Liver
Lung
Pancreas
Pediatric
Pharmacy
Small Bowel
Presentation Type: Lecture/Didactic Symposium
Proposed Session Title: Top Papers in Transplant Infectious Diseases
Proposed Moderators: Jay Fishman, MGH and Atul Humar, University of Toronto
Presentation #1: Top 5 Papers: Viruses
Proposed Speaker: Lara Danziger-Isakov, University of Cincinnati
Presentation #2: Top 5 Papers: Bacteria
Proposed Speaker: Shirish Huprikar, Mount Sinai
Presentation #3: Top 5 Papers: Fungi et al.
Proposed Speaker: Robin Avery, Johns Hopkins
Goals and Objectives: To highlight top Transplant ID papers
ID Proposals_Final
Name: Shirish Huprikar
Institution: Mount Sinai
Email: [email protected]
Camille Kotton – middle tier priority
Good speakers
Nothing on antifungals at ATC2016, good to have at ATC2017
Did you submit this proposal on behalf of an ASTS or AST committee?: Yes
If yes, please indicate which committee: ID COP
Specialty: Heart
Infectious Disease
Kidney
Liver
Lung
Pancreas
Pediatric
Pharmacy
Small Bowel
Presentation Type: Lecture/Didactic Symposium
Proposed Session Title: Antifungal Testing, Prevention, and Treatment Stewardship in SOT
Proposed Moderators: Jay Fishman, MGH and Shirish Huprikar, Mount Sinai
Presentation #1: Fungus Among Us: State of the Art Diagnostics
Proposed Speaker: John Baddley, UAB
Presentation #2: An Ounce or a Pound of Fungal Prevention?
Proposed Speaker: Shahid Husain, University of Toronto
Presentation #3: Antifungal Treatment in SOT
Proposed Speaker: Shmuel Shoham, Johns Hopkins
Goals and Objectives: 1. To highlight rational approaches to fungal infection diagnostic testing
2. To highlight the approaches to prevention of fungal infection in SOT
3. To highlight the unique considerations for treatment in SOT
ID Proposals_Final
Name: Michele Morris
Institution: University of Miami Miller School of Medicine
Email: [email protected]
Camille Kotton – accept – middle tier priority for ID – would try hard to include, excellent speakers
Did you submit this proposal on behalf of an ASTS or AST committee?: No
If yes, please indicate which committee:
Specialty: Infectious Disease
Presentation Type: Lecture/Didactic Symposium
Proposed Session Title: Emerging Infections in the Age of Global Warning - Implications for
Transplantation
Proposed Moderators: Camille Kotton, Massachusetts General Hospital and Raymund Razonnable,
Mayo Clinic, Rochester
Presentation #1: Zika Virus Infections - Screening Recommendations and Outcome Data
Proposed Speaker: Clarisse Machado, University of Sao Paolo, Brazil
Presentation #2: Nontuberculous Mycobacteria Infections - Management of Transplant Candidates and
Recipients
Proposed Speaker: Michele I. Morris, University of Miami Miller School of Medicine, Miami, FL
Presentation #3: Strongyloides Infection Post-Transplant - Screening & Management of Donors &
Recipients
Proposed Speaker: Emily Blumberg, University of Pennsylvania, Philadelphia, PA – consider eplacing
with Ricardo de la Hoz, Texas, to highlighted talented young members (EB not a guru on this topic per
se)
Goals and Objectives: To update transplant practitioners on the risks and challenges of pre-transplant
screening and post-transplant management of these emerging pathogens.
ID Proposals_Final
Name: Elmi Muller
Institution: University of Cape Town
Email: [email protected]
Camille Kotton – brilliant session (my favorite of all), outstanding speakers, should be very well
attended, top tier for ID and entire transplant community
Did you submit this proposal on behalf of an ASTS or AST committee?: No
If yes, please indicate which committee:
Specialty: Infectious Disease
Kidney
Liver
Presentation Type: Lecture/Didactic Symposium
Proposed Session Title: HIV positive transplantation
Proposed Moderators: Michelle Morris, Director, Immunocompromised Host Section Division of
Infectious Diseases University of Miami Miller School of Medicine and Jayme Locke, University of
Alabama at Birmingham
Presentation #1: HIV positive to positive transplantation - first year results and outcomes in the USA
Proposed Speaker: Christine Durand, Johns Hopkins University
Presentation #2: HIV positive to positive transplantation in South Africa - the unexpected outcomes and
lessons learned
Proposed Speaker: Elmi Muller, University of Cape Town
Presentation #3: HIV positive transplantations: results with Maraviroc and MTOR inhibitors
Proposed Speaker: Peter Stock, University of California San Francisco
Goals and Objectives: Improving knowledge about the use of HIV positive donors.
Improving knowledge about new ways of managing recipients who are HIV positive.
ID Proposals_Final
Name: christina chung
Institution: Drexel University
Email: [email protected]
Camille Kotton – this belongs elsewhere not in ID
Did you submit this proposal on behalf of an ASTS or AST committee?: No
If yes, please indicate which committee:
Specialty: Dermatology
Presentation Type: Lecture/Didactic Symposium
Proposed Session Title: Transplant Dermatology: New evidence, new approaches, and a fresh mandate
for interdisciplinary collaboration
Proposed Moderators: Christina Lee Chung, MD, Drexel University and Sarah T. Arron, MD, PhD,
University of California
Presentation #1: Morbidity and Mortality
Proposed Speaker: Sarah T. Arron, MD, PhD, University of California San Francisco
Presentation #2: Forging an Interdisciplinary Approach to Managing Post-Transplant Dermatological
Care
Proposed Speaker: Christina Lee Chung, MD, Drexel University
Presentation #3: Transplant Dermatology in Skin of Color: New Data Demands New Approaches
Proposed Speaker: Ellen N. Pritchett, MD, Henry Ford Hospital
Goals and Objectives: 1. To define post-transplant mortality from skin cancer and identify risk factors
2. To describe models on which to build an effective and comprehensive transplant dermatology
program
3. To identify differences in post-transplant dermatologic disease and skin cancer risk between White
and non-White transplant recipients
ID Proposals_Final
ID Proposals_Final